Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00991458 · ClinicalTrials.gov registry record · Phase 2
Study of Cyclosporine in Post-LASIK Patients
A Phase 2 study, sponsored by Allergan.
- Completed
- Registry status
- Phase 2
- Development phase
- 621
- Enrollment target
NCT00991458 is a Phase 2 study that has completed, run by Allergan. The registered enrollment target is 621 participants.
The verdict
NCT00991458, a Phase 2 study, has completed, sponsored by Allergan.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 621 participants
- Enrollment target
Study Summary
This study will evaluate the safety and efficacy of Cyclosporine 0.005% and 0.010% eye drops administered twice daily before and following LASIK surgery.
Interventions
- DRUG Cyclosporine 0.010% eye drops
- DRUG Cyclosporine 0.005% eye drops
- DRUG Placebo (Vehicle for Cyclosporine)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 621 participants |
| Start Date | 2009-10 |
| Est. Completion | 2011-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00991458
The ClinicalTrials.gov registry entry for NCT00991458 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 621 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Allergan, which has 314 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Cyclosporine 0.010% eye drops is the first listed.
NCT00991458 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00991458 about?
NCT00991458 is a clinical study titled "Study of Cyclosporine in Post-LASIK Patients". This study will evaluate the safety and efficacy of Cyclosporine 0.005% and 0.010% eye drops administered twice daily before and following LASIK surgery.
What is the current status of trial NCT00991458?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 621 participants. The study started on 2009-10. Estimated completion is 2011-04.
What interventions are being tested in trial NCT00991458?
The interventions under investigation include: Cyclosporine 0.010% eye drops (DRUG), Cyclosporine 0.005% eye drops (DRUG), Placebo (Vehicle for Cyclosporine) (DRUG).
Who is sponsoring clinical trial NCT00991458?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.